DOCU241206C94000
- 0.46
- -0.13-22.03%
DocuSign Newsroom
DocuSign (DOCU) Q3 Pre-Earnings: Here's What to Expect
Should You Buy, Sell, or Hold Docusign Stock Before Q3 Earnings?
Express News | JP Morgan Maintains Underweight on DocuSign, Raises Price Target to $70
DocuSign Price Target Raised to $95.00/Share From $80.00 by Jefferies
Jefferies Maintains DocuSign(DOCU.US) With Buy Rating, Raises Target Price to $95
Express News | DocuSign Inc : Jefferies Raises Target Price to $95 From $80
Tesla, Super Micro, Stellantis, XPeng, Nvidia, and More Stock Market Movers
Earnings report preview | Software stocks are set to release earnings reports in succession, with salesforce (CRM.US) as the focus.
Enterprise software giant Salesforce (CRM.US) will announce its third-quarter performance after the market close on Tuesday Eastern Time. Q3 revenue is expected to grow by 7% to 9.3 billion US dollars, with adjusted earnings per share expected to increase by 16% to $2.44 per share.
Salesforce, Kroger, Lululemon, Ulta Beauty, and More Stocks to Watch This Week
Earnings Week Ahead: CRM, DOCU, OKTA, ZS, S, MRVL, LULU, DG, and More
Earnings Preview: DocuSign to Report Financial Results Post-market on December 05
Catalyst Watch: November Jobs, OPEC+ Meeting, Marvell, Salesforce Earnings
Shares of Software Companies Are Trading Lower Possibly Amid Overall Market Weakness. Multiple Software Stocks Fell After Q3 Financial Results.
Express News | Shares of Software Companies Are Trading Lower Possibly Amid Overall Market Weakness. Multiple Software Stocks Fell After Q3 Financial Results
DocuSign (DOCU) Stock Slides as Market Rises: Facts to Know Before You Trade
Express News | Shares of Semiconductor Stocks Are Trading Higher, With Stocks Broadly Rising Amid a Drop in Yields. President-elect Trump Nominated Scott Bessent as Treasury Secretary
Is DocuSign Stock a Buy or Sell Ahead of Q3 Earnings?
DocuSign (NASDAQ:DOCU) Is Experiencing Growth In Returns On Capital
DocuSign Stock Soars to 52-week High, Reaches $84.25
Docusign Stock Rises 20% in a Month: Should You Hold or Fold?